Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancerBeibei Ni, Lei Wang, Zixu Yuan et al.|International Journal of Oncology|2015Cited by 77
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancerYanhong Deng, Jianping Wang, Li Wang et al.|Molecular Oncology|2015Cited by 60
Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal CancerJianwei Zhang, Yanhong Deng, Meijin Huang et al.|Clinical Colorectal Cancer|2019Cited by 41